体积 6, 问题 4 (2009)
评论文章
Lifestyle management: preventing Type 2 diabetes and cardiovascular complications
Rebecca S Stiegler, Paul Z Zimmet, Adrian J Cameron and Jonathan E Shaw
研究文章
Chemotherapy-induced nausea and vomiting in Portugal: incidence versus healthcare provider estimations and effect on quality of life
Jose Dinis, Tami Wisniewski, Antonio Moreira, Joao Raposo, Larry Ma & Thomas A Burke
评论文章
Glycemic control and cardiovascular disease in a high-risk chronic kidney disease population
Rachandeep Singh, Ravi Nistala, Samy I McFarlane and Adam Whaley-Connell
评论文章
Novel strategies and future landmarks in the treatment of irritable bowel syndrome
Richard Roka, Krisztina Gecse and Tibor Wittmann
特别报告
Pharmacogenomics and the prevention of vascular complications in diabetes mellitus
Dan Farbstein and Andrew P Levy
案例报告
Efficacy of clobazam monotherapy in three cases of symptomatic localization-related epilepsy in children
Toshiyuki Iwasaki, Yutaka Nonoda, Kenji Takei, Nozomi Hosoda and Masahiro Ishii
前言
Diabetes and cardiovascular disease: time for individualized risk reduction
Samy I McFarlane and James R Sowers
药物评价
Colesevelam hydrochloride: a bile acid sequestrant for glycemic control and treatment of dyslipidemia in Type 2 diabetes mellitus
Prasanth N Surampudi, Prathima Nagireddy and Vivian A Fonseca
社论
Will computational simulation in congenital heart disease ever make it out of the engineering lab and into the clinic?
Alison L Marsden and Jeffrey A Feinstein
评论文章
Hyperglycemia, dyslipidemia and hypertension in older people with diabetes: the benefits of cardiovascular risk reduction
Siobhan HM Brown and Ahmed H Abdelhafiz
